Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBL-514 for Reducing Abdominal and Thigh Subcutaneous Fat (Stage 1)
NCT04575467Phase 2Completed
- Sponsor
- Caliway Biopharmaceuticals
- Start
- Dec 2020
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CBL-514 in subcutaneous fat, sponsored by Caliway Biopharmaceuticals. Started Dec 2020; status: completed.
02
Drugs
CBL-514
03
Conditions
subcutaneous fat
Beyond the preview
Go deeper on NCT04575467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04575467.